Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita

Sancy A. Leachman, Robyn P. Hickerson, Peter R. Hull, Frances J. D. Smith, Leonard M. Milstone, E. Birgitte Lane, Sherri J. Bale, Dennis R. Roop, W. H. Irwin McLean, Roger L. Kaspar

    Research output: Contribution to journalReview articlepeer-review

    94 Citations (Scopus)

    Abstract

    The field of science and medicine has experienced a flood of data and technology associated with the human genome project. Over 10,000 human diseases have been genetically defined, but little progress has been made with respect to the clinical application of this knowledge. A notable exception to this exists for pachyonychia congenita (PC), a rare, dominant-negative keratin disorder. The establishment of a non-profit organization, PC Project, has led to an unprecedented coalescence of patients, scientists, and physicians with a unified vision of developing novel therapeutics for PC. Utilizing the technological by-products of the human genome project, such as RNA interference (RNAi) and quantitative RT-PCR (qRT-PCR), physicians and scientists have collaborated to create a candidate siRNA therapeutic that selectively inhibits a mutant allele of KRT6A, the most commonly affected PC keratin. In vitro investigation of this siRNA demonstrates potent inhibition of the mutant allele and reversal of the cellular aggregation phenotype. In parallel, an allele-specific quantitative real-time RT-PCR assay has been developed callus samples in preparation for clinical trials. If clinical efficacy is ultimately demonstrated, this "first-in-skin" siRNA may herald a paradigm shift in the treatment of dominant-negative genetic disorders. (c) 2008 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

    Original languageEnglish
    Pages (from-to)151-157
    Number of pages7
    JournalJournal of Dermatological Science
    Volume51
    Issue number3
    DOIs
    Publication statusPublished - Sep 2008

    Keywords

    • pachyonychia
    • congenita
    • keratin
    • genodermatoses
    • RNAi
    • siRNA
    • gene therapy
    • EPIDERMOLYSIS-BULLOSA SIMPLEX
    • RNA INTERFERENCE
    • STEM-CELLS
    • KERATIN
    • DISEASE
    • MUTATION
    • GENOME
    • MODEL
    • MICE
    • K6A

    Fingerprint

    Dive into the research topics of 'Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita'. Together they form a unique fingerprint.

    Cite this